{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T16:30:41Z","timestamp":1789317041784,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T00:00:00Z","timestamp":1639526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T00:00:00Z","timestamp":1639526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["Glycosylation Signatures for Precision Medicine project, GlySign, Grant No. 722095)"],"award-info":[{"award-number":["Glycosylation Signatures for Precision Medicine project, GlySign, Grant No. 722095)"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["Glycosylation Signatures for Precision Medicine project, GlySign, Grant No. 722095)"],"award-info":[{"award-number":["Glycosylation Signatures for Precision Medicine project, GlySign, Grant No. 722095)"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["Glycosylation Signatures for Precision Medicine project, GlySign, Grant No. 722095)"],"award-info":[{"award-number":["Glycosylation Signatures for Precision Medicine project, GlySign, Grant No. 722095)"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["Glycosylation Signatures for Precision Medicine project, GlySign, Grant No. 722095)"],"award-info":[{"award-number":["Glycosylation Signatures for Precision Medicine project, GlySign, Grant No. 722095)"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009425","name":"Landsteiner Foundation for Blood Transfusion Research","doi-asserted-by":"publisher","award":["Grant No. 1546"],"award-info":[{"award-number":["Grant No. 1546"]}],"id":[{"id":"10.13039\/100009425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009425","name":"Landsteiner Foundation for Blood Transfusion Research","doi-asserted-by":"publisher","award":["Grant No. 1546"],"award-info":[{"award-number":["Grant No. 1546"]}],"id":[{"id":"10.13039\/100009425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009425","name":"Landsteiner Foundation for Blood Transfusion Research","doi-asserted-by":"publisher","award":["Grant No. 1546"],"award-info":[{"award-number":["Grant No. 1546"]}],"id":[{"id":"10.13039\/100009425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009425","name":"Landsteiner Foundation for Blood Transfusion Research","doi-asserted-by":"publisher","award":["Grant No. 1546"],"award-info":[{"award-number":["Grant No. 1546"]}],"id":[{"id":"10.13039\/100009425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004350","name":"Studienstiftung des Deutschen Volkes","doi-asserted-by":"publisher","award":["Scholarship"],"award-info":[{"award-number":["Scholarship"]}],"id":[{"id":"10.13039\/501100004350","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>As a lymphoid organ, the spleen hosts a wide range of immune cell populations, which not only remove blood-borne antigens, but also generate and regulate antigen-specific immune responses. In particular, the splenic microenvironment has been demonstrated to play a prominent role in adaptive immune responses to enveloped viral infections and alloantigens. During both types of immunizations, antigen-specific immunoglobulins G (IgGs) have been characterized by the reduced amount of fucose present on N-linked glycans of the fragment crystallizable (Fc) region. These glycans are essential for mediating the induction of immune effector functions. Therefore, we hypothesized that a spleen may modulate humoral responses and serve as a preferential site for afucosylated IgG responses, which potentially play a role in immune thrombocytopenia (ITP) pathogenesis. To determine the role of the spleen in IgG-Fc glycosylation, we performed IgG subclass-specific liquid chromatography\u2013mass spectrometry (LC\u2013MS) analysis of Fc glycosylation in a large cohort of individuals splenectomized due to trauma, due to ITP, or spherocytosis. IgG-Fc fucosylation was consistently increased after splenectomy, while no effects for IgG-Fc galactosylation and sialylation were observed. An increase in IgG1- and IgG2\/3-Fc fucosylation level upon splenectomy has been reported here for the first time, suggesting that immune responses occurring in the spleen may be particularly prone to generate afucosylated IgG responses. Surprisingly, the level of total IgG-Fc fucosylation was decreased in ITP patients compared to healthy controls. Overall, our results suggest a yet unrecognized role of the spleen in either the induction or maintenance of afucosylated IgG responses by B cells.\n<\/jats:p>","DOI":"10.1038\/s41598-021-03196-w","type":"journal-article","created":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T11:05:44Z","timestamp":1639566344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A functional spleen contributes to afucosylated IgG in humans"],"prefix":"10.1038","volume":"11","author":[{"given":"Iwona","family":"Wojcik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"de Neef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minke A. E.","family":"Rab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"Meek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okke","family":"de Weerdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Wuhrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Ellen","family":"van der Schoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap J.","family":"Zwaginga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masja","family":"de Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Falck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gestur","family":"Vidarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,15]]},"reference":[{"key":"3196_CR1","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nri1669","volume":"5","author":"RE Mebius","year":"2005","unstructured":"Mebius, R. E. & Kraal, G. Structure and function of the spleen. Nat. Rev. Immunol. 5, 606\u2013616 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"3196_CR2","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1182\/blood-2007-11-123844","volume":"111","author":"M Mamani-Matsuda","year":"2008","unstructured":"Mamani-Matsuda, M. et al. The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells. Blood 111, 4653\u20134659 (2008).","journal-title":"Blood"},{"key":"3196_CR3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nri3383","volume":"13","author":"A Cerutti","year":"2013","unstructured":"Cerutti, A., Cols, M. & Puga, I. Marginal zone B cells: Virtues of innate-like antibody-producing lymphocytes. Nat. Rev. Immunol. 13, 118\u2013132 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"3196_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0140-6736(10)61493-6","volume":"378","author":"A Di Sabatino","year":"2011","unstructured":"Di Sabatino, A., Carsetti, R. & Corazza, G. R. Post-splenectomy and hyposplenic states. Lancet 378, 86\u201397 (2011).","journal-title":"Lancet"},{"key":"3196_CR5","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/pr.2015.211","volume":"79","author":"P Giordano","year":"2016","unstructured":"Giordano, P. et al. B-cell hyperfunction in children with immune thrombocytopenic purpura persists after splenectomy. Pediatr. Res. 79, 262\u2013270 (2016).","journal-title":"Pediatr. Res."},{"key":"3196_CR6","doi-asserted-by":"publisher","first-page":"e23164","DOI":"10.1371\/journal.pone.0023164","volume":"6","author":"PU Cameron","year":"2011","unstructured":"Cameron, P. U. et al. Splenectomy associated changes in IgM memory B cells in an adult spleen registry cohort. PLoS ONE 6, e23164 (2011).","journal-title":"PLoS ONE"},{"key":"3196_CR7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1136\/adc.45.239.114","volume":"45","author":"MJ Schumacher","year":"1970","unstructured":"Schumacher, M. J. Serum immunoglobulin and transferrin levels after childhood splenectomy. Arch. Dis. Child. 45, 114\u2013117 (1970).","journal-title":"Arch. Dis. Child."},{"key":"3196_CR8","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1002\/eji.201343577","volume":"43","author":"MM Rosado","year":"2013","unstructured":"Rosado, M. M. et al. Preserved antibody levels and loss of memory B cells against pneumococcus and tetanus after splenectomy: Tailoring better vaccination strategies. Eur. J. Immunol. 43, 2659\u20132670 (2013).","journal-title":"Eur. J. Immunol."},{"key":"3196_CR9","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.vaccine.2015.02.026","volume":"33","author":"P Nived","year":"2015","unstructured":"Nived, P., Jorgensen, C. S. & Settergren, B. Vaccination status and immune response to 13-valent pneumococcal conjugate vaccine in asplenic individuals. Vaccine 33, 1688\u20131694 (2015).","journal-title":"Vaccine"},{"key":"3196_CR10","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/bjh.14053","volume":"174","author":"ME Sonneveld","year":"2016","unstructured":"Sonneveld, M. E. et al. Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia. Br. J. Haematol. 174, 310\u2013320 (2016).","journal-title":"Br. J. Haematol."},{"key":"3196_CR11","doi-asserted-by":"publisher","first-page":"eabc8378","DOI":"10.1126\/science.abc8378","volume":"371","author":"MD Larsen","year":"2021","unstructured":"Larsen, M. D. et al. Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity. Science 371, eabc8378 (2021).","journal-title":"Science"},{"key":"3196_CR12","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1172\/JCI65708","volume":"123","author":"ME Ackerman","year":"2013","unstructured":"Ackerman, M. E. et al. Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. J. Clin. Invest. 123, 2183\u20132192 (2013).","journal-title":"J. Clin. Invest."},{"key":"3196_CR13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1126\/science.aai8128","volume":"355","author":"TT Wang","year":"2017","unstructured":"Wang, T. T. et al. IgG antibodies to dengue enhanced for FcgammaRIIIA binding determine disease severity. Science 355, 395\u2013398 (2017).","journal-title":"Science"},{"key":"3196_CR14","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3389\/fimmu.2017.00877","volume":"8","author":"G Dekkers","year":"2017","unstructured":"Dekkers, G. et al. Decoding the human immunoglobulin G-glycan repertoire reveals a spectrum of fc-receptor- and complement-mediated-effector activities. Front. Immunol. 8, 877 (2017).","journal-title":"Front. Immunol."},{"key":"3196_CR15","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3389\/fimmu.2017.00646","volume":"8","author":"B Peschke","year":"2017","unstructured":"Peschke, B., Keller, C. W., Weber, P., Quast, I. & Lunemann, J. D. Fc-Galactosylation of human immunoglobulin gamma isotypes improves C1q binding and enhances complement-dependent cytotoxicity. Front. Immunol. 8, 646 (2017).","journal-title":"Front. Immunol."},{"key":"3196_CR16","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nrrheum.2017.146","volume":"13","author":"M Seeling","year":"2017","unstructured":"Seeling, M., Bruckner, C. & Nimmerjahn, F. Differential antibody glycosylation in autoimmunity: Sweet biomarker or modulator of disease activity?. Nat. Rev. Rheumatol. 13, 621\u2013630 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"3196_CR17","doi-asserted-by":"publisher","first-page":"4522","DOI":"10.1021\/pr400589m","volume":"12","author":"A Bondt","year":"2013","unstructured":"Bondt, A. et al. Association between galactosylation of immunoglobulin G and improvement of rheumatoid arthritis during pregnancy is independent of sialylation. J. Proteom. Res. 12, 4522\u20134531 (2013).","journal-title":"J. Proteom. Res."},{"key":"3196_CR18","doi-asserted-by":"publisher","first-page":"8187","DOI":"10.1038\/s41598-017-08654-y","volume":"7","author":"ME Sonneveld","year":"2017","unstructured":"Sonneveld, M. E. et al. Patients with IgG1-anti-red blood cell autoantibodies show aberrant Fc-glycosylation. Sci. Rep. 7, 8187 (2017).","journal-title":"Sci. Rep."},{"key":"3196_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cellimm.2018.07.009","volume":"333","author":"I Gudelj","year":"2018","unstructured":"Gudelj, I., Lauc, G. & Pezer, M. Immunoglobulin G glycosylation in aging and diseases. Cell. Immunol. 333, 65\u201379 (2018).","journal-title":"Cell. Immunol."},{"key":"3196_CR20","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3389\/fimmu.2018.00553","volume":"9","author":"G Dekkers","year":"2018","unstructured":"Dekkers, G., Rispens, T. & Vidarsson, G. Novel concepts of altered immunoglobulin G galactosylation in autoimmune diseases. Front. Immunol. 9, 553 (2018).","journal-title":"Front. Immunol."},{"key":"3196_CR21","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1021\/pr401213z","volume":"13","author":"WJ Fokkink","year":"2014","unstructured":"Fokkink, W. J. et al. IgG Fc N-glycosylation in Guillain-Barre syndrome treated with immunoglobulins. J. Proteom. Res. 13, 1722\u20131730 (2014).","journal-title":"J. Proteom. Res."},{"key":"3196_CR22","doi-asserted-by":"publisher","first-page":"e81448","DOI":"10.1371\/journal.pone.0081448","volume":"8","author":"S Ogata","year":"2013","unstructured":"Ogata, S. et al. Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G. PLoS ONE 8, e81448 (2013).","journal-title":"PLoS ONE"},{"key":"3196_CR23","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1038\/s41598-020-59651-7","volume":"10","author":"DE Schmidt","year":"2020","unstructured":"Schmidt, D. E. et al. IgG-Fc glycosylation before and after rituximab treatment in immune thrombocytopenia. Sci. Rep. 10, 3051 (2020).","journal-title":"Sci. Rep."},{"key":"3196_CR24","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/trf.12880","volume":"55","author":"R Kapur","year":"2015","unstructured":"Kapur, R. et al. Prophylactic anti-D preparations display variable decreases in Fc-fucosylation of anti-D. Transfusion 55, 553\u2013562 (2015).","journal-title":"Transfusion"},{"key":"3196_CR25","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/bjh.12965","volume":"166","author":"R Kapur","year":"2014","unstructured":"Kapur, R. et al. Low anti-RhD IgG-Fc-fucosylation in pregnancy: A new variable predicting severity in haemolytic disease of the fetus and newborn. Br. J. Haematol. 166, 936\u2013945 (2014).","journal-title":"Br. J. Haematol."},{"key":"3196_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1182\/blood-2013-09-527978","volume":"123","author":"R Kapur","year":"2014","unstructured":"Kapur, R. et al. A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy. Blood 123, 471\u2013480 (2014).","journal-title":"Blood"},{"key":"3196_CR27","doi-asserted-by":"publisher","first-page":"e289","DOI":"10.3324\/haematol.2016.162685","volume":"102","author":"D Evers","year":"2017","unstructured":"Evers, D. et al. Absence of the spleen and the occurrence of primary red cell alloimmunization in humans. Haematologica 102, e289\u2013e292 (2017).","journal-title":"Haematologica"},{"key":"3196_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41590-020-00828-7","volume":"22","author":"S Chakraborty","year":"2021","unstructured":"Chakraborty, S. et al. Proinflammatory IgG Fc structures in patients with severe COVID-19. Nat. Immunol. 22, 67\u201373 (2021).","journal-title":"Nat. Immunol."},{"key":"3196_CR29","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1126\/science.abc7303","volume":"372","author":"S Bournazos","year":"2021","unstructured":"Bournazos, S. et al. Antibody fucosylation predicts disease severity in secondary dengue infection. Science 372, 1102\u20131105 (2021).","journal-title":"Science"},{"key":"3196_CR30","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.4049\/jimmunol.1900985","volume":"203","author":"AR Temming","year":"2019","unstructured":"Temming, A. R. et al. Functional attributes of antibodies, effector cells, and target cells affecting NK cell-mediated antibody-dependent cellular cytotoxicity. J. Immunol. 203, 3126\u20133135 (2019).","journal-title":"J. Immunol."},{"key":"3196_CR31","doi-asserted-by":"publisher","first-page":"e1005315","DOI":"10.1371\/journal.ppat.1005315","volume":"12","author":"ME Ackerman","year":"2016","unstructured":"Ackerman, M. E. et al. Polyfunctional HIV-specific antibody responses are associated with spontaneous HIV control. PLoS Pathog. 12, e1005315 (2016).","journal-title":"PLoS Pathog."},{"key":"3196_CR32","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1126\/scitranslmed.abf8654","volume":"13","author":"W Hoepel","year":"2021","unstructured":"Hoepel, W. et al. High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages. Sci. Transl. Med. 13, 596 (2021).","journal-title":"Sci. Transl. Med."},{"key":"3196_CR33","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1074\/mcp.R112.026005","volume":"12","author":"G Zauner","year":"2013","unstructured":"Zauner, G. et al. Glycoproteomic analysis of antibodies. Mol. Cell Proteom. 12, 856\u2013865 (2013).","journal-title":"Mol. Cell Proteom."},{"key":"3196_CR34","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","volume":"5","author":"G Vidarsson","year":"2014","unstructured":"Vidarsson, G., Dekkers, G. & Rispens, T. IgG subclasses and allotypes: From structure to effector functions. Front. Immunol. 5, 520 (2014).","journal-title":"Front. Immunol."},{"key":"3196_CR35","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/iid3.22","volume":"2","author":"AC Vestrheim","year":"2014","unstructured":"Vestrheim, A. C. et al. A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines. Immun. Inflamm. Dis. 2, 76\u201391 (2014).","journal-title":"Immun. Inflamm. Dis."},{"key":"3196_CR36","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1074\/mcp.O116.058503","volume":"15","author":"R Plomp","year":"2016","unstructured":"Plomp, R., Bondt, A., de Haan, N., Rombouts, Y. & Wuhrer, M. Recent advances in clinical glycoproteomics of immunoglobulins (Igs). Mol. Cell. Proteom. 15, 2217\u20132228 (2016).","journal-title":"Mol. Cell. Proteom."},{"key":"3196_CR37","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fimmu.2018.00129","volume":"9","author":"ME Sonneveld","year":"2018","unstructured":"Sonneveld, M. E. et al. Fc-glycosylation in human IgG1 and IgG3 is similar for both total and anti-red-blood cell anti-K antibodies. Front. Immunol. 9, 129 (2018).","journal-title":"Front. Immunol."},{"key":"3196_CR38","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1021\/acs.jproteome.6b00038","volume":"15","author":"N de Haan","year":"2016","unstructured":"de Haan, N., Reiding, K. R., Driessen, G., van der Burg, M. & Wuhrer, M. Changes in healthy human IgG Fc-glycosylation after birth and during early childhood. J. Proteom. Res. 15, 1853\u20131861 (2016).","journal-title":"J. Proteom. Res."},{"key":"3196_CR39","doi-asserted-by":"publisher","first-page":"12669","DOI":"10.1073\/pnas.1108455108","volume":"108","author":"C Ferrara","year":"2011","unstructured":"Ferrara, C. et al. Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose. Proc. Natl. Acad. Sci. U. S. A. 108, 12669\u201312674 (2011).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"3196_CR40","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.4049\/jimmunol.168.7.3675","volume":"168","author":"M Kuwana","year":"2002","unstructured":"Kuwana, M., Okazaki, Y., Kaburaki, J., Kawakami, Y. & Ikeda, Y. Spleen is a primary site for activation of platelet-reactive T and B cells in patients with immune thrombocytopenic purpura. J. Immunol. 168, 3675\u20133682 (2002).","journal-title":"J. Immunol."},{"key":"3196_CR41","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3389\/fimmu.2018.00880","volume":"9","author":"M Swinkels","year":"2018","unstructured":"Swinkels, M. et al. Emerging concepts in immune thrombocytopenia. Front. Immunol. 9, 880 (2018).","journal-title":"Front. Immunol."},{"key":"3196_CR42","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00277-016-2738-3","volume":"95","author":"R Ahmed","year":"2016","unstructured":"Ahmed, R. et al. Long-term outcome following splenectomy for chronic and persistent immune thrombocytopenia (ITP) in adults and children: Splenectomy in ITP. Ann. Hematol. 95, 1429\u20131434 (2016).","journal-title":"Ann. Hematol."},{"key":"3196_CR43","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1172\/JCI65689","volume":"123","author":"M Mahevas","year":"2013","unstructured":"Mahevas, M. et al. B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells. J. Clin. Invest. 123, 432\u2013442 (2013).","journal-title":"J. Clin. Invest."},{"key":"3196_CR44","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.exphem.2016.07.004","volume":"44","author":"R Aslam","year":"2016","unstructured":"Aslam, R. et al. The spleen dictates platelet destruction, anti-platelet antibody production, and lymphocyte distribution patterns in a murine model of immune thrombocytopenia. Exp. Hematol. 44, 924-930e921 (2016).","journal-title":"Exp. Hematol."},{"key":"3196_CR45","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s12185-017-2335-9","volume":"107","author":"MAE Rab","year":"2018","unstructured":"Rab, M. A. E. et al. Persistent changes in circulating white blood cell populations after splenectomy. Int. J. Hematol. 107, 157\u2013165 (2018).","journal-title":"Int. J. Hematol."},{"key":"3196_CR46","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1196\/annals.1313.014","volume":"1050","author":"BF Hoyer","year":"2005","unstructured":"Hoyer, B. F., Manz, R. A., Radbruch, A. & Hiepe, F. Long-lived plasma cells and their contribution to autoimmunity. Ann. N. Y. Acad. Sci. 1050, 124\u2013133 (2005).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"3196_CR47","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/oxfordjournals.jbchem.a022794","volume":"128","author":"A Matsumoto","year":"2000","unstructured":"Matsumoto, A., Shikata, K., Takeuchi, F., Kojima, N. & Mizuochi, T. Autoantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation. J. Biochem. 128, 621\u2013628 (2000).","journal-title":"J. Biochem."},{"key":"3196_CR48","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/JLB.3HI1217-500R","volume":"104","author":"SK Vadrevu","year":"2018","unstructured":"Vadrevu, S. K. et al. Frontline science: Plasma and immunoglobulin G galactosylation associate with HIV persistence during antiretroviral therapy. J. Leukoc. Biol. 104, 461\u2013471 (2018).","journal-title":"J. Leukoc. Biol."},{"key":"3196_CR49","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/infdis\/jiu388","volume":"211","author":"CH Ho","year":"2015","unstructured":"Ho, C. H. et al. Aberrant serum immunoglobulin G glycosylation in chronic hepatitis B is associated with histological liver damage and reversible by antiviral therapy. J. Infect. Dis. 211, 115\u2013124 (2015).","journal-title":"J. Infect. Dis."},{"key":"3196_CR50","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1074\/mcp.RA119.001860","volume":"19","author":"TC Martin","year":"2020","unstructured":"Martin, T. C. et al. Decreased immunoglobulin G core fucosylation, a player in antibody-dependent cell-mediated cytotoxicity, is associated with autoimmune thyroid diseases. Mol. Cell Proteom. 19, 774\u2013792 (2020).","journal-title":"Mol. Cell Proteom."},{"key":"3196_CR51","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.3324\/haematol.2014.110213","volume":"100","author":"JJ Zwaginga","year":"2015","unstructured":"Zwaginga, J. J. et al. Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients. Haematologica 100, e90-92 (2015).","journal-title":"Haematologica"},{"key":"3196_CR52","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-1-4939-6493-2_4","volume":"1503","author":"D Falck","year":"2017","unstructured":"Falck, D., Jansen, B. C., de Haan, N. & Wuhrer, M. High-throughput analysis of IgG Fc glycopeptides by LC-MS. Methods Mol. Biol. 1503, 31\u201347 (2017).","journal-title":"Methods Mol. Biol."},{"key":"3196_CR53","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1021\/acs.jproteome.6b00171","volume":"15","author":"BC Jansen","year":"2016","unstructured":"Jansen, B. C. et al. LaCyTools: A targeted liquid chromatography-mass spectrometry data processing package for relative quantitation of glycopeptides. J. Proteom. Res. 15, 2198\u20132210 (2016).","journal-title":"J. Proteom. Res."},{"key":"3196_CR54","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1074\/mcp.M114.039537","volume":"13","author":"A Bondt","year":"2014","unstructured":"Bondt, A. et al. Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes. Mol. Cell. Proteom. 13, 3029\u20133039 (2014).","journal-title":"Mol. Cell. Proteom."},{"key":"3196_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-015-0450-1","volume":"12","author":"M Wuhrer","year":"2015","unstructured":"Wuhrer, M. et al. Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid. J. Neuroinflamm. 12, 1\u201314 (2015).","journal-title":"J. Neuroinflamm."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-03196-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-03196-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-03196-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T16:36:28Z","timestamp":1676046988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-03196-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,15]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["3196"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-03196-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,15]]},"assertion":[{"value":"16 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I.W. is employed by Genos Ltd. No potential conflict of interest was reported by the remaining authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24045"}}